Medpace is a scientifically-driven, global full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services for drug, biologic, and device programs. Medpace’s physician-led, high-science, and disciplined operating approach leverages regulatory and therapeutic expertise to accelerate the global development of safe and effective medical therapeutics…More across all major areas including oncology, cardiovascular, metabolic/diabetes, infectious disease, and neuroscience.
REPORT RATINGS
4.8 / 5.0 (215)
Medpace Holdings, Inc. reports have an aggregate usefulness score of 4.8 based on 215 reviews.